DaVita Clinical Research to Present Research Results on Hospital Readmissions, Anemia Management, Nutrition Business Wire ORLANDO, Fla. -- April 04, 2013 DaVita Clinical Research^® (DCR^®), a specialty contract research organization with services spanning the full spectrum of drug and device development, today announced that company representatives will present four abstracts at National Kidney Foundation's (NKF) 2013 Spring Clinical Meeting, which takes place April 2-6, 2013, in Orlando, Fla. The NKF Spring Clinical Meeting is a platform for the nation's leading renal health care providers to learn about new developments in the field of nephrology and kidney care practices. Researchers from DaVita^®, the dialysis division of DaVita Healthcare Partners Inc., and DCR will present results from a number of innovative clinical improvement programs originating from DaVita and its research partners. DCR provides a collaborative bridge between DaVita’s health care community and the academic, pharmaceutical and biotech research community. DCR and DaVita share a dedication to improving the health and quality of life for kidney care patients. DCR’s recent research includes analyses of hospital readmissions and length of stay, new findings on anemia management and work on nutritional issues. “Clinical research is a critical part of DaVita’s work to alleviate suffering and reduce health care costs related to chronic kidney disease and end stage renal disease,” said Mahesh Krishnan, M.D., M.P.H., M.B.A., F.A.S.N., vice president of clinical research. “These abstracts are the result of significant investments in clinical research, and we believe the findings demonstrate the value of that investment.” At this year's NKF Spring Clinical Meeting, DaVita will focus on several key research initiatives in end-stage renal disease, including: *“Analysis of Length of Stay (LOS) and Readmissions Among End-Stage Renal Disease (ESRD) and Non-ESRD Patients Using a 5% Sample of Inpatient Claims Data From the Centers for Medicare and Medicaid Services (CMS) (2007-2008)”[Poster 128] *“Evaluating Hemoglobin (HB) Trends and the Potential Impact on Transfusions (TFNS) Under the New ESA Guidelines in Patients with ESRD at a Large Dialysis Organization” [Poster 48] *“Timing of Albumin Testing Affects Corrected Calcium Levels” [Poster 115] *“Multiple Anemia Protocols Permit Anemia Control and Physician Choice” [Poster 48] DaVita, DaVita Clinical Research, DCR and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita Healthcare Partners Inc. All other trademarks are the property of their respective owners. About DaVita DaVita is the dialysis division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of kidney care in the United States, DaVita delivers dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of Dec.31, 2012, DaVita operated or provided administrative services at 1,954 outpatient dialysis centers located in the United States serving approximately 153,000 patients. The company also operated 36 outpatient dialysis centers located in eight countries outside the United States. DaVita supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit DaVita.com. About DaVita Clinical Research DaVita Clinical Research(DCR), a wholly owned subsidiary ofDaVita HealthCare Partners Inc., uses its extensive, applied database and real-world healthcare experience to assist pharmaceutical and medical device companies in the design, recruitment, and completion of clinical trials including retrospective and prospective pragmatic trials.DCR’s scientific and clinical expertise spans the lifecycle of product development with more than 150 client companies. DCR’sBiorepository,Early Clinical Researchunit (Phase I-IIa) andClinical Development (Phase IIb through post-marketing)network of physicians and investigative sites, data research,Health Economics & Outcomes Research,Central Laboratory, andMedical Communicationsare focused on providing world-class research in both complex/specialty populations and therapeutic areas, and especially in CKD and ESRD populations. To learn more about DCR, visitwww.davitaclinicalresearch.com. Contact: DaVita Clinical Research Bianca Violante Office: 303-876-661 Mobile: 443-417-6044 Bianca.Violante@DaVita.com
DaVita Clinical Research to Present Research Results on Hospital Readmissions, Anemia Management, Nutrition
Press spacebar to pause and continue. Press esc to stop.